Shannon Marshall
13Patents
5h-index
30Co-inventors
62Inventor score
Filing activity: Nov 12, 1997 → Apr 6, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9205148B2 | Antibodies and other molecules that bind B7-H1 and PD-1 | Chemistry; Metallurgy | 66 | Active |
| US8338569B2 | FGFR extracellular domain acidic region muteins | Chemistry; Metallurgy | 37 | Active |
| US9676854B2 | Anti-B7-H4 antibodies and their uses | Chemistry; Metallurgy | 9 | Active |
| US9011853B2 | B7-H4 fusion proteins and methods of use thereof | Physics | 5 | Active |
| US6054711A | Methods for identifying biological macromolecule interactions with compounds, particularly in complex mixtures | Physics | 5 | Expired |
| US7399829B2 | Variants of RANKL protein | Chemistry; Metallurgy | 3 | Expired |
| US7381792B2 | Variants of RANKL protein | Human Necessities | 3 | Expired |
| US9957312B2 | B7-H4 fusion proteins and methods of use thereof | Physics | 3 | Active |
| US8324165B2 | Compositions for treating arthritis comprising HG1023575 polypeptide | Chemistry; Metallurgy | 2 | Active |
| US8575312B2 | Compositions and methods of use for MGD-CSF in disease treatment | Human Necessities | 2 | Active |
| US7459527B2 | BMP-7 variants with improved properties | Human Necessities | 2 | Expired |
| US9175065B2 | FGFR extracellular domain acidic region muteins | Chemistry; Metallurgy | 0 | Active |
| US8178109B2 | Compositions and methods of use for MGD-CSF in disease treatment | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.